US House expands probe on McNeil GMP to "phantom recall" contractors
This article was originally published in Scrip
Executive Summary
A congressional oversight committee investigating GMP issues at Johnson & Johnson's McNeil facility in Fort Washington, Pennsylvania, has initiated a new probe. The chairman of the House Committee on Oversight and Government Reform, Edolphus Towns, has asked certain contracting companies whether they were hired by J&J in late 2008 to go into retail stores and secretly purchase suspect tablets of adult Motrin IB 200 (ibuprofen) as part of an alleged plan to remove the product from store shelves without initiating a formal recall.